Your doctor can submit the appeal with clinical documentation of your body mass index (BMI), weight-related comorbid condition, and previous weight loss attempts to demonstrate medical necessity
It sounds great on paper, but you can see why its not something we can really recommend to anyone
It is mostly used by athletes to stimulate their body to become more efficient in transforming fat into energy
doi:10.1002/jcph.2373 195
On the heels of basic research on the venom of Gila monsters in the preceding decades,1 exenatide secured the first US FDA approval in the class on April 28, 2005.2 While the prominent GLP-1 brand names are household names today, the class was off to a relatively slow start at first five years passed before it reached blockbuster status (US$1 billion (770 million) in sales), and another five went by before the first formal approval of a GLP-1 drug indicated for obesity became a reality.3 Last year saw sales for the class cross $50 billion and, with another 40% in revenue growth in store for 2025, the GLP-1 segment of the pharmaceutical industry is firmly in the rapid growth phase of the market, per Investment Bank Consensus